| Revenue growth | Value |
|---|---|
| 1Y (TTM) | -38% |
| 3Y CAGR | +22% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +48% |
| 3Y CAGR | +49% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Astrazeneca Pharma IndiaASTRAZEN | ₹8,405.50 -123.50 (1.45%) | 21,286.25 | 113.51 | 24.39 | ||
PfizerPFIZER | ₹4,534.60 -4.70 (0.10%) | 20,766.73 | 28.74 | 4.94 | ||
₹1,454.10 +23.50 (1.64%) | 19,822.74 | 30.61 | 5.08 | |||
Granules IndiaGRANULES | ₹785.45 +3.35 (0.43%) | 19,386.39 | 32.58 | 3.81 |